“otsuka-pharmaceutical” Archives

in
Entry Author Date Location
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More 04/24/20 National
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund 03/11/20 Europe
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex 01/06/20 New York
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More 07/13/18 National
Otsuka Ramps Up Its Antibody Game with $430M Visterra Acquisition 07/11/18 Boston
FibroGen Pushes Forward With Anemia Pill in China, But Big Test Awaits 01/30/17 San Francisco
West Coast Biotech Roundup: Amgen, Ariosa, Avanir, Audentes & More 12/04/14 San Diego
Alkermes CEO Leans on Internal Pipeline as Bydureon Hangs Out in the Penalty Box 11/15/10 Boston
A Nobel Laureate’s Stealthy Biotech, Its Japanese Pharma Backer, and the Englishman In Charge 10/14/10 Boston
Seattle Genetics’ Home Run, Acucela Growing Ties to Japan, Calistoga’s Wall Street Guy, & More Seattle-Area Life Sciences News 09/30/10 Seattle
Acucela, Strengthening Ties With Japan’s Otsuka, Gets Right to Develop New Glaucoma Drug 09/27/10 Seattle
Burrill on How Dx Will Beat Rx, VCs Rip Into Pols, Tekmira Strikes Pfizer Deal, & More Seattle-Area Life Sciences News 03/18/10 Seattle
Acucela Enters Fast-Growth Phase As Macular Degeneration Drug Advances to Key Trial 01/20/10 Seattle
Acucela Cuts Staff, Shifting Focus to Development of Eye Disease Drugs 10/03/08 Seattle
Seattle Entrepreneurs Call Bay Area VCs, Amazon Sells XOs, Tableau Taps $10M, ZymoGenetics Gives Up Drug Rights, & More Deals News 09/09/08 Seattle
Acucela Strikes Deal With Otsuka Pharmaceutical to Develop Drug for Eye Disease 09/04/08 Seattle
Page 1 of 1